3.70 (0.22%) Sun Pharmaceutical Industries has reported results for the second quarter ended September 30, 2013.
The company has reported a fall of 98.30% in its net profit of Rs 6.30 crore for the quarter as compared to Rs 370.62 crore for the same quarter in the previous year. Total income of the company has decreased by 44.02% at Rs 643.74 crore for quarter under review as compared to Rs 1149.93 crore for the quarter ended September 30, 2012.
On the consolidated basis, the group has reported over 4 fold jump in net profit after taxes, minority interest and share of profit / (loss) of associates at Rs 1362.30 crore as compared to Rs 319.64 crore in the same quarter previous year. Total income of the group rose 52.19% to Rs 4311.63 crore for quarter under review as against Rs 2833.13 crore in corresponding quarter previous year.